Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

FIVE at FIVE AU: Tech and Telcos drag ASX lower; Energy a bright spot

Published 26/03/2024, 04:03 pm
© Reuters FIVE at FIVE AU: Tech and Telcos drag ASX lower; Energy a bright spot

The ASX traded lower into the afternoon, to end the day down 0.38% at 7,782 points, following pain on Wall Street overnight. The Tech (-1.51%) and Telco (-0.99%) sectors weighed on the market.

However, the Energy sector (+0.53%) ended the day higher. After the oil price held its biggest weekly gain overnight, oil and gas majors Woodside and Santos each finished higher, up 1.06% and 0.4% respectively. Beach Energy (ASX:BPT) gained 2.6% to $1.78 after being raised to a buy rating by Morgans.

After emerging from a trading halt, ASX biotech Mesoblast gained 44% today after the US FDA allowed the company to re-submit a licence application for its Ryoncil (remestemcel-L) product, for the treatment of children with steroid-refractory acute graft versus host disease (SR-aGVHD) – a devastating and life-threatening complication of a bone marrow transplant.

29Metals lost more than a quarter of its market value today after the copper producer suspended operations at its Capricorn Copper Mine in Queensland due to further heavy rainfall.

Westpac Consumer Sentiment out

After a promising improvement in February, Westpac’s consumer confidence index dipped by 1.8% for March as consumer confidence remains “very, very low” by historical standards. At 84.4, the sentiment index is well below the long-run average of 100.7.

Consumers were more pessimistic after the RBA’s March cash rate decision than those surveyed before, likely due to the downgrade in expectations of the timing of future rate cuts.

The negative consumer sentiment continues to impact retail trade — the food and beverage sector, in particular. This sector is experiencing much higher rates of business failures than all other industries.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Just over 7% of businesses in the food and beverage sector closed down during the past year, well above the 4.6% average rate across all industries.

Five at five

FireFly Metals takes another “pivotal step” at Green Bay by securing nearby port access

FireFly Metals Ltd (ASX:FFM) is making positive progress with its strategy to establish the Green Bay Copper-Gold Project in Newfoundland, Canada, as a major operation with world-scale copper production, including securing valuable port access just 6 kilometres from the project.

Read more

Race Oncology key asset RC220 passes milestone with manufactured batch confirmed for human IV use

The first Good Manufacturing Practice (cGMP) batch of RC220, the proprietary bisantrene formulation of Race Oncology Ltd (ASX:RAC, OTC:RAONF), is complete and it has received a Certificate of Analysis (CoA).

Read more

Latin Resources delivers even more high-grade results from Salinas Lithium Project

The drilling success continues for Latin Resources Ltd (ASX:LRS, OTC:LRSRF) at Colina deposit within the Salinas Lithium Project in Brazil, where high-grade infill results have confirmed the top-tier quality of the project.

Read more

Anson Resources uncovers up to 29.5% zinc and 28.87% lead at Ajana with silver to boot

Anson Resources Ltd (ASX:ASN, OTCQB:ANSNF) has fielded results it describes as "exceptional" from recent drilling at the Ajana Base and Precious Metals Project in Western Australia's Mid-West.

Read more

Flynn Gold reveals polymetallic strike and depth potential at Firetower

Final assay results from a recent 4-hole diamond drilling program by Flynn Gold Ltd (ASX:FG1) at Firetower polymetallic prospect within the Firetower Project in northwest Tasmania have been received and reviewed with gold, cobalt, tungsten and copper returned.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read more

On your six

Arovella Therapeutics fully funded to pursue Phase 1 blood cancer clinical trials for ALA-101 after $12.5 million placement

Arovella Therapeutics Ltd (ASX:ALA) has secured the funding necessary to carry out its Phase 1 clinical trials on invariant Natural Killer T (iNKT) cell therapy platform treatment ALA-101, assessing its effect in patients with CD19-positive non-Hodgkin’s lymphoma.

Read more

One to watch

Gold Hydrogen delivers “amazing” hydrogen and helium results

Gold Hydrogen Ltd (ASX:GHY) managing director Neil McDonald joins Jonathan Jackson in the Proactive studio to discuss the recent “amazing” findings of natural hydrogen and helium at the Ramsay Project in South Australia.

Watch more

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.